Clinical Research on Diabetic Complications

doi:10.3390/books978-3-03943-826-6

Reprint

Download Flyer

Clinical Research on Diabetic Complications

Edited by

March 2021

202 pages

ISBN978-3-03943-825-9 (Hardback)
ISBN978-3-03943-826-6 (PDF)

https://doi.org/10.3390/books978-3-03943-826-6

Free download (PDF)

This book is a reprint of the Special Issue Clinical Research on Diabetic Complications that was published in

Medicine & Pharmacology

Public Health & Healthcare

Summary

Refrigeration, air conditioning, and heat pumps (RACHP) have an important impact on the final energy uses of many sectors of modern society, such as residential, commercial, industrial, transport, and automotive.

Moreover, RACHP also have an important environmental impact due to the working fluids that deplete the stratospheric ozone layer, which are being phased out according to the Montreal Protocol (1989). Last, but not least, high global working potential (GWP), working fluids (directly), and energy consumption (indirectly) are responsible for a non-negligible quota of greenhouse gas (GHG) emissions in the atmosphere, thus impacting climate change.

Format

Hardback

License

Keywords

burnt-out diabetes; chronic kidney disease (CKD); dialysis; end-stage renal disease (ESRD); incident diabetes mellitus (DM); insulin resistance; dementia; dipeptidyl-peptidase IV inhibitors; diabetes mellitus; type 2; Alzheimer’s disease; dementia; vascular; diabetes; dementia; microperimetry; Alzheimer’s disease; type 2 diabetes mellitus; glucose fluctuations; sarcopenia; diabetic retinopathy; type 1 diabetes; quality of life; treatment satisfaction; patient-reported outcomes; type 1 diabetes; plaque characteristics; carotid plaque; echogenic plaque; diabetic foot syndrome; vascular disease; fibroblast growth factor 23; Klotho; inflammation; dermal electrochemical conductance; diabetes mellitus; neuropathy; primary care; screening; sudomotor reflex; prediabetes; arterial stiffness; baPWV; aspirin; primary prevention; diabetes mellitus; meta-analysis; trial sequential analysis; sCD36; type 1 diabetes mellitus; type 2 diabetes mellitus; branched-chain amino acids; metabolomics; NMR spectroscopy; type 2 diabetes mellitus; diabetes; diabetic kidney disease; reno-cardiovascular protection; sodium-glucose co-transporter 2 inhibitors; glucagon-like peptide-1 receptor agonists; dipeptidyl peptidase 4 inhibitors; diabetes; obesity; bariatric surgery; diabetic macroangiopathy; cardiovascular disease; heart disease; cerebrovascular disease; peripheral artery disease; diabetic foot disease; diabetic microangiopathy; diabetic retinopathy; diabetic kidney disease; diabetic neuropathy